Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion

Summary

This is a prospective, open-label , multicenter randomized controlled trial, with 248 cases in 50 centers planned for a period of 2 years. The aim of the study is to evaluate the safety and effectiveness of microparticles packaging chemotherapeutic drugs (MPCD) therapy on the treatment of malignant pleural effusion (MPE) in patients with advanced lung cancer or breast cancer.

Timeline

Start

2019-10-15

Primary completion

2021-01-15

Completion

2021-06-15

Drugs

Indications